This treatment is very effective for a specific group of colon cancer patients.
Immunotherapy is a type of cancer treatment that harnesses your own immune system to fight cancer. Immunotherapy treats many cancer types—including colon cancer. “We know that 5 percent or so of colon cancers will have a good response to immune checkpoint inhibitors,” says Elliot Newman, MD, chief of surgical oncology at Lenox Hill Hospital, Northwell Health System.
How Immunotherapy Works to Fight Cancer
Immunotherapies help the immune system recognize a tumor as something different than the normal tissues in the body. One of these immunotherapy approaches is a class of medications called checkpoint inhibitors.
“The reason they’re called immune checkpoint inhibitors is because our body has an immune system that has to be kept in check so it doesn’t destroy our cells,” says Dr. Newman. To do this, it uses “checkpoints”—which are proteins on immune cells that must be turned on (or off) to trigger an immune response.
Cancer cells sometimes use these checkpoints to essentially hide from and avoid being attacked by the immune system. “Cancer cells have learned to exploit that and have the ability to get around the immune checkpoint and flourish,” says Dr. Newman.
“What we learned by using checkpoint inhibitors is we can turn off this checkpoint inhibition, or the “breaks” in the immune system, and allow the immune system to work against the cancer cells,” says Dr. Newman. “And this therapy, for the right situation, can be very effective in controlling cancer and improving outcomes and survival.”
The Type of Colon Cancer Immunotherapy Can Treat
Immunotherapy isn’t appropriate for all colon cancer patients: It’s used to treat patients with advanced colorectal cancer, and only patients whose tumors have specific genetic mutations. A doctor determines if the tumor has those mutations by doing a biopsy.
Immunotherapy is still new as an option for cancer treatment, and it’s potential role for treating advanced colon cancer is still being discovered.
“Right now, the only place where we’ve seen some efficacy is in a small percentage of patients, approximately 5 percent of patients, who have a deficiency in what are known as mismatch repair (MMR) genes,” says Dr. Newman. “However, studies are ongoing to look at the role of these immune checkpoint inhibitors and other forms of immunotherapy in all types of colon cancer.”
Dr. Newman is the chief of surgical oncology at Lenox Hill Hospital, Northwell Health System, and a professor at Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.
00:00:00.000 --> 00:00:02.532
00:00:02.533 --> 00:00:05.799
Immunotherapy is being heavily investigated
00:00:05.800 --> 00:00:09.999
in many types of cancer, including colon and rectal cancer.
00:00:10.000 --> 00:00:15.299
Right now, the only place where we've seen some efficacy
00:00:15.300 --> 00:00:17.666
is in a small percentage of patients,
00:00:17.667 --> 00:00:20.399
approximately 5 percent of patients,
00:00:20.400 --> 00:00:26.366
who have a deficiency in what are known as mismatch repair genes.
00:00:26.367 --> 00:00:30.032
However, studies are ongoing to look at the role
00:00:30.033 --> 00:00:32.732
of these immune checkpoint inhibitors
00:00:32.733 --> 00:00:38.332
and other forms of immunotherapy in all types of colon cancer.
00:00:38.333 --> 00:00:43.666
00:00:43.667 --> 00:00:46.532
Immunotherapy is a method of treatment
00:00:46.533 --> 00:00:50.066
that involves using our body's own immune system.
00:00:50.067 --> 00:00:53.499
And we know that 5 percent or so of colon cancers
00:00:53.500 --> 00:01:00.099
will have a good response to the immune checkpoint inhibitors.
00:01:00.100 --> 00:01:02.999
The reason they're called immune checkpoint inhibitors
00:01:03.000 --> 00:01:06.332
is because our body has an immune system
00:01:06.333 --> 00:01:11.132
that has to be kept in check so it doesn't destroy ourselves,
00:01:11.133 --> 00:01:14.132
something referred to as autoimmunity.
00:01:14.133 --> 00:01:17.899
Cancer cells have learned to exploit that,
00:01:17.900 --> 00:01:23.632
and have the ability to get around the immune checkpoint,
00:01:23.633 --> 00:01:26.699
and can flourish.
00:01:26.700 --> 00:01:29.466
What we learn by using immune checkpoint inhibitors
00:01:29.467 --> 00:01:34.266
is we can turn off this checkpoint inhibition,
00:01:34.267 --> 00:01:37.066
or the brakes on the immune system,
00:01:37.067 --> 00:01:41.399
and allow the immune system to work against the cancer cells.
00:01:41.400 --> 00:01:47.232
And this therapy, for the right situation, can be very effective
00:01:47.233 --> 00:01:52.799
in controlling cancer and improving outcome and survival.
00:01:52.800 --> 00:01:58.500
Patient education: Colorectal cancer treatment; metastatic cancer (Beyond the Basics). UpToDate. (Accessed on December 20, 2019 at https://www.uptodate.com/contents/colorectal-cancer-treatment-metastatic-cancer-beyond-the-basics)Immunotherapy for Colorectal Cancer. American Cancer Society. (Accessed on December 20, 2019 at https://www.cancer.org/cancer/colon-rectal-cancer/treating/immunotherapy.html)